Tafenoquine
Tafenoquine (WR 238605) is an 8-aminoquinoline. Tafenoquine is an anti-malarial prophylactic agent[1].
Product Specifications
CAS Number
[106635-80-7]
Product Name Alternative
WR 238605
UNSPSC
12352005
Hazard Statement
H315, H319, H320
Target
Parasite
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/Tafenoquine.html
Purity
99.77
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1=CC(OC)=NC2=C1C(OC3=CC=CC(C(F)(F)F)=C3)=C(OC)C=C2NC(CCCN)C
Molecular Formula
C24H28F3N3O3
Molecular Weight
463.49
Precautions
H315, H319, H320
References & Citations
[1]Marcsisin SR, et al. Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malar J. 2014 Jan 3;13:2.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
Plasmodium
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15083244 1 Vial
Lentiviral human LCP2 shRNA (UAS) - Lentiviral human LCP2 shRNA (UAS, RFP) (100)
Ask
View Details